Is mid‐gestational uterine artery Doppler still useful in a setting with routine first‐trimester pre‐eclampsia screening? A cohort study
Open Access
- 20 March 2023
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 130 (9) , 1128-1134
Abstract
Objective: To evaluate whether routine mid‐gestational uterine artery Doppler (UtAD) modifies the risk for preterm pre‐eclampsia after first‐trimester combined pre‐eclampsia screening.Design: Retrospective cohort study.Setting: London Tertiary Hospital.Population: A cohort of 7793 women with singleton pregnancies, first‐trimester pre‐eclampsia screening using the Fetal Medicine Foundation (FMF) algorithm and UtAD pulsatility index (PI) assessment at the mid‐gestation ultrasound.Methods: Pregnancies were divided into four groups: high risk in both trimesters (H1H2), high risk in the first but not in the second trimester (H1L2), low risk in the first but high risk in the second trimester (L1H2) and low risk in both trimesters (L1L2).Main outcome measures: Small for gestational age (SGA), hypertensive disorders of pregnancy (HDP) and stillbirth.Results: In this cohort, 600 (7.7%) and 620 (7.9%) women were designated as being at high risk in the first and second trimesters, respectively. Preterm pre‐eclampsia was more prevalent in the H1L2 group (4.5%) than in women considered at low risk in the first trimester (0.4%, p < 0.0001). The prevalence of preterm pre‐eclampsia in the L1H2 group (3.3%) was significantly lower than that in women considered at high risk in the first trimester (7.0%, p = 0.0076), and was higher than that observed in the L1L2 group (0.2%, p < 0.0001). The prevalence of SGA and term HDP followed similar trends.Conclusions: Pre‐eclampsia risk after first‐trimester FMF pre‐eclampsia screening may be stratified through mid‐gestational routine UtAD assessment. Pregnancy care should not be de‐escalated for low mid‐gestational UtAD resistance in women classified as being at high risk in the first trimester. The escalation of care may be justified in women at low risk but with high mid‐gestational UtAD resistance.Keywords
This publication has 26 references indexed in Scilit:
- Aspirin versus Placebo in Pregnancies at High Risk for Preterm PreeclampsiaNew England Journal of Medicine, 2017
- The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysisAmerican Journal of Obstetrics and Gynecology, 2017
- Do knowledge of uterine artery resistance in the second trimester and targeted surveillance improve maternal and perinatal outcome? UTOPIA study: a randomized controlled trialUltrasound in Obstetrics & Gynecology, 2016
- Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19–24 weeks’ gestationAmerican Journal of Obstetrics and Gynecology, 2016
- Mid‐pregnancy fetal biometry, uterine artery Doppler indices and maternal demographic characteristics: role in prediction of small‐for‐gestational‐age birthActa Obstetricia et Gynecologica Scandinavica, 2015
- Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre‐eclampsiaUltrasound in Obstetrics & Gynecology, 2008
- Reference ranges for uterine artery mean pulsatility index at 11–41 weeks of gestationUltrasound in Obstetrics & Gynecology, 2008
- Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysisCanadian Medical Association Journal, 2008
- The role of uterine artery Doppler in predicting adverse pregnancy outcomeBest Practice & Research Clinical Obstetrics & Gynaecology, 2004
- Randomized controlled trial using low‐dose aspirin in the prevention of pre‐eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestationUltrasound in Obstetrics & Gynecology, 2003